BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

553 related articles for article (PubMed ID: 2188935)

  • 1. [Leprosy. Pathogenesis--classification--diagnosis--treatment].
    Stingl P
    Hautarzt; 1990 Mar; 41(3):126-30. PubMed ID: 2188935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allocation of patients to paucibacillary or multibacillary drug regimens for the treatment of leprosy--a comparison of methods based mainly on skin smears as opposed to clinical methods--alternative clinical methods for classification of patients.
    Becx-Bleumink M
    Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):292-303. PubMed ID: 2071986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histopathological lesions of apparently normal skin in leprosy patients.
    Rashed HA; Mearag I; Saleh NM; Saied A
    J Egypt Soc Parasitol; 2009 Dec; 39(3):933-42. PubMed ID: 20120756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sub-polar lepromatous leprosy localized to the face.
    George M; Rajan U; George S; Pakran J; Thomas S
    Dermatol Online J; 2010 Sep; 16(9):8. PubMed ID: 20875329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Childhood leprosy in a tertiary-care hospital in Delhi, India: a reappraisal in the post-elimination era.
    Singal A; Sonthalia S; Pandhi D
    Lepr Rev; 2011 Sep; 82(3):259-69. PubMed ID: 22125934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histopathology of skin and nerve and clinical classification in leprosy patients.
    Lakshmi TS; Rao PN; Krishna AV; Kumar EC
    Indian J Lepr; 1996; 68(3):258-60. PubMed ID: 8889614
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy of single-dose ROM therapy plus low-dose convit vaccine as an adjuvant for treatment of paucibacillary leprosy patients with a single skin lesion.
    Majumder V; Saha B; Hajra SK; Biswas SK; Saha K
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):283-90. PubMed ID: 11221091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistence of lepromatous granuloma in clinically cured cases of leprosy.
    Desikan P; Desikan KV
    Int J Lepr Other Mycobact Dis; 1995 Sep; 63(3):417-21. PubMed ID: 7594925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and treatment of leprosy type 1 (reversal) reaction.
    Sung SM; Kobayashi TT
    Cutis; 2015 Apr; 95(4):222-6. PubMed ID: 25942024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leprosy. An update: definition, pathogenesis, classification, diagnosis, and treatment.
    Eichelmann K; González González SE; Salas-Alanis JC; Ocampo-Candiani J
    Actas Dermosifiliogr; 2013 Sep; 104(7):554-63. PubMed ID: 23870850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histological assessment of dermal nerve damage occurring during multidrug therapy for leprosy.
    Jain M; Singh N; Bhatia A; Arora VK
    Int J Lepr Other Mycobact Dis; 2000 Jun; 68(2):167-71. PubMed ID: 11036497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leprosy. Recognition and treatment.
    Ramos-e-Silva M; Rebello PF
    Am J Clin Dermatol; 2001; 2(4):203-11. PubMed ID: 11705247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative evaluation of immunotherapeutic efficacy of BCG and mw vaccines in patients of borderline lepromatous and lepromatous leprosy.
    Narang T; Kaur I; Kumar B; Radotra BD; Dogra S
    Int J Lepr Other Mycobact Dis; 2005 Jun; 73(2):105-14. PubMed ID: 16830653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hansen's disease: case report and review of literature].
    Concha R M; Cossio T ML; Salazar S I; Fich S F; Pérez C C; González B S
    Rev Chilena Infectol; 2008 Feb; 25(1):64-9. PubMed ID: 18273528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histopathological changes in the arrector pili muscle of normal appearing skin in leprosy patients.
    Budhiraja V; Rastogi R; Khare S; Khare A; Krishna A
    Int J Infect Dis; 2010 Sep; 14 Suppl 3():e70-2. PubMed ID: 20207571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Facial tuberculoid leprosy: case report.
    Ali K; Sittampalam G; Malik MA
    Br J Oral Maxillofac Surg; 2011 Jan; 49(1):70-2. PubMed ID: 20188445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wade's histoid leprosy: three clinical presentations.
    Pereyra SB; Danielo CA; Ponssa GJ; Consigli JE; Papa MB; Ghirardi G
    Int J Dermatol; 2007 Sep; 46(9):944-6. PubMed ID: 17822497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lepromatous leprosy.
    Booth AV; Kovich OI
    Dermatol Online J; 2007 Jan; 13(1):9. PubMed ID: 17511942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.
    Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.